Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Dr. Rojas-Caro will oversee the medical strategy and clinical development of Aeglea’s pipeline
May 16, 2016
By: Kristin Brooks
Managing Editor, Contract Pharma
Sandra Rojas-Caro, M.D. has been appointed chief medical officer at Aeglea BioTherapeutics, Inc., a biotechnology company developing enzyme-based therapeutics to treat inborn errors of metabolism and cancer. Dr. Rojas-Caro will oversee the medical strategy and clinical development of Aeglea’s pipeline. She brings more than 15 years of protein therapeutics and small molecule drug development experience. Previously, she served as group vice president of Clinical Research and Development at Synageva BioPharma, where she was instrumental in leading the medical team and contributed to the approval of Kanuma (sebelipase alpha) for the treatment of lysosomal acid lipase deficiency, and advancing the clinical development of other metabolism programs. Following the acquisition of Synageva by Alexion, Dr. Rojas-Caro served as vice president and R&D project team leader for SBC-103, where she supported the integration post-merger. Dr. Rojas-Caro also held roles in clinical and translational research with increasing levels of responsibility at Roche, Array BioPharma and Pfizer. “We are extremely pleased to have Dr. Rojas-Caro join the Aeglea leadership team as chief medical officer. She brings expertise and knowledge in the area of protein-based rare disease therapeutics and metabolism, and a track record of advancing the clinical development of needed drug therapies. Her leadership is anticipated to bring us closer to realizing our goal of improving the lives of patients,” said David G. Lowe, PhD, co-founder, president and chief executive officer of Aeglea.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !